Age-linked variation noted in melanoma management
(HealthDay)—Age-related variation is seen in the characteristics and management of melanoma, according to a study published online Aug. 14 in JAMA Dermatology.
Aug 15, 2013
0
0
Archive: 15/08/2013
New study puts a price on drug-resistant TB cases in EU
A new study has calculated the average cost per case of TB in the EU. The findings suggest the economic burden of TB far outweighs the costs of investing in more effective vaccines.
Aug 15, 2013
Preventive antibiotics for tuberculosis reduce deaths among people with HIV disease
As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances ...
Aug 15, 2013
Simple blood pressure cuff inflation reduces heart injury from bypass surgery
The study, led by Professor Gerd Heusch of the Institute for Pathophysiology, and Dr Matthias Thielmann, of the Department of Thoracic and Cardiovascular Surgery, both based at the University School of Medicine Essen, Germany, ...
Aug 15, 2013
More potent anti-clotting drugs with angiography may benefit patients with acute chest pain
Current methods to treat acute coronary syndrome conditions, such as heart attack, include artery-clearing procedures (e.g., percutaneous coronary intervention or coronary artery bypass grafting) with medications, or medications ...
Aug 15, 2013
Study shows both a Mediterranean diet and diets low in available carbohydrates protect against type 2 diabetes
New research shows that a Mediterranean-style diet and diets low in available carbohydrates can offer protection against type 2 diabetes. The study is published in Diabetologia, the journal of the European Association for ...
Aug 15, 2013
Obesity remains very high in 13 US states (Update)
Adult obesity in the U.S. still isn't budging, the latest government survey shows.
Aug 15, 2013
0
0
ITN type 1 diabetes study identifies subset of patients with strong response to therapy
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, ...
Aug 15, 2013
Researchers discover molecular target for the bacterial infection brucellosis
UC Davis scientists have uncovered a potential drug target for the development of an effective therapy against the debilitating, chronic form of the bacterial disease brucellosis, which primarily afflicts people in Mediterranean ...
Aug 15, 2013
